Cargando…

Advancing personalized care in hemophilia A: ten years’ experience with an advanced category antihemophilic factor prepared using a plasma/albumin-free method

Detailed analysis of data from studies of recombinant antihemophilic factor produced using a plasma/albumin-free method (rAHF-PFM) in previously treated patients showed a substantial level of interpatient variation in pharmacokinetics (PKs), factor VIII dosing, and annualized bleed rate (ABR), sugge...

Descripción completa

Detalles Bibliográficos
Autores principales:	Berntorp, Erik, Spotts, Gerald, Patrone, Lisa, Ewenstein, Bruce M
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2014
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3984057/ https://www.ncbi.nlm.nih.gov/pubmed/24741292 http://dx.doi.org/10.2147/BTT.S53456

Ejemplares similares

Antihemophilic factor (recombinant) plasma/albumin-free method for the management and prevention of bleeding episodes in patients with hemophilia A
por: Pipe, Steven
Publicado: (2009)

Improved Pharmacokinetics with BAY 81-8973 Versus Antihemophilic Factor (Recombinant) Plasma/Albumin-Free Method: A Randomized Pharmacokinetic Study in Patients with Severe Hemophilia A
por: Shah, Anita, et al.
Publicado: (2016)

Comparative pharmacokinetics of plasma- and albumin-free recombinant factor VIII in children and adults: the influence of blood sampling schedule on observed age-related differences and implications for dose tailoring
por: BJÖRKMAN, S, et al.
Publicado: (2010)

Review of antihemophilic factor injection for the routine prophylaxis of bleeding episodes and risk of joint damage in severe hemophilia A
por: Rossbach, Hans-Christoph
Publicado: (2010)

“Antihemophilic factor is not the only answer for all factor VIII deficiencies.” Case report of odontogenic infection in a patient with hemophilia A, complicated by factor VIII inhibitors, and managed by transfusion of antihemophilic factor and factor VIII inhibitor bypass activity
por: Sudheesh, K. M., et al.
Publicado: (2016)

Phase 4 Safety and Efficacy Study of Antihemophilic Factor (Recombinant) in Previously Treated Chinese Patients With Severe/Moderately Severe Hemophilia A
por: Zhao, Yongqiang, et al.
Publicado: (2021)

A Prospective Observational Study of Antihemophilic Factor (Recombinant) Prophylaxis Related to Physical Activity Levels in Patients with Hemophilia A in the United States (SPACE)
por: Konkle, Barbara A, et al.
Publicado: (2021)

Results of a randomized phase III/IV trial comparing intermittent bolus versus continuous infusion of antihaemophilic factor (recombinant) in adults with severe or moderately severe haemophilia A undergoing major orthopaedic surgery
por: Pabinger, Ingrid, et al.
Publicado: (2021)

Pharmacokinetic parameter driven outcomes model predicts a reduction in bleeding events associated with BAY 81–8973 versus antihemophilic factor (recombinant) plasma/albumin-free method in a Chinese healthcare setting
por: Chen, Rong, et al.
Publicado: (2022)

Recent Advances in Hemophilia Gene Therapy
por: Karimipoor, Morteza
Publicado: (2019)

Gene Therapy in Hemophilia: Recent Advances
por: Rodríguez-Merchán, E. Carlos, et al.
Publicado: (2021)

Advanced therapies for the treatment of hemophilia: future perspectives
por: Liras, Antonio, et al.
Publicado: (2012)

Recent Advances in the Treatment of Hemophilia: A Review
por: Marchesini, Emanuela, et al.
Publicado: (2021)

In Vitro Assessment of von Willebrand Factor in Cryoprecipitate, Antihemophilic Factor/VWF Complex (Human), and Recombinant von Willebrand Factor
por: Colling, Meaghan E., et al.
Publicado: (2019)

The elevated prevalence of risk factors for chronic liver disease among ageing people with hemophilia and implications for treatment
por: Qvigstad, Christian, et al.
Publicado: (2018)

Socioeconomic participation of persons with hemophilia: Results from the sixth hemophilia in the Netherlands study
por: van Balen, Erna C., et al.
Publicado: (2022)

Convenience Comparison Study of Reconstitution Devices for the Blood Coagulation Factor VIII Products Rurioctocog Alfa Pegol and Antihemophilic Factor (Recombinant)
por: Ueda, Hitoshi, et al.
Publicado: (2020)

Anti-hemophilic factor (recombinant), plasma/albumin-free method (octocog-alpha; ADVATE(®)) in the management of hemophilia A
por: Shapiro, Amy D
Publicado: (2007)

Polyethylene Glycol Exposure with Antihemophilic Factor (Recombinant), PEGylated (rurioctocog alfa pegol) and Other Therapies Indicated for the Pediatric Population: History and Safety
por: Stidl, Reinhard, et al.
Publicado: (2018)

Living with a “hemophilia‐free mind” – The new ambition of hemophilia care?
por: Krumb, Evelien, et al.
Publicado: (2021)

Treatment of hemophilia: a review of current advances and ongoing issues
por: Coppola, Antonio, et al.
Publicado: (2010)

Acquired hemophilia A in a patient with advanced prostate cancer
por: Girardi, Daniel da Motta, et al.
Publicado: (2015)

Bispecific Antibodies and Advances in Non–Gene Therapy Options in Hemophilia
por: Shima, Midori
Publicado: (2020)

The management of patients with congenital von Willebrand disease during surgery or other invasive procedures: focus on antihemophilic factor/von Willebrand factor complex
por: Franchini, Massimo, et al.
Publicado: (2007)

Advanced computing and systems for security: volume ten
por: Chaki, Rituparna, et al.
Publicado: (2019)

Direct comparison of two extended-half-life recombinant FVIII products: a randomized, crossover pharmacokinetic study in patients with severe hemophilia A
por: Shah, Anita, et al.
Publicado: (2019)

Mobile Health Technology for the Personalized Therapy of Hemophilia
por: Dirzu, Noemi, et al.
Publicado: (2021)

Albumin-Fusion Recombinant FIX in the Management of People with Hemophilia B: An Evidence-Based Review
por: Pasca, Samantha, et al.
Publicado: (2022)

Direct comparison of two extended half-life PEGylated recombinant FVIII products: a randomized, crossover pharmacokinetic study in patients with severe hemophilia A
por: Solms, Alexander, et al.
Publicado: (2020)

Recent Advances in Sample Preparation for Cosmetics and Personal Care Products Analysis
por: Celeiro, Maria, et al.
Publicado: (2021)

The Reduction of Salt in Different Cheese Categories: Recent Advances and Future Challenges
por: Tidona, Flavio, et al.
Publicado: (2022)

Category clustering calculator for free recall
por: Senkova, Olesya, et al.
Publicado: (2012)

Acquired Hemophilia A in an advanced age patient of hispanic origin: a case report
por: Rivera Cora, Nalyssa I., et al.
Publicado: (2017)

Recent advancements in erythrocytes, platelets, and albumin as delivery systems
por: Xu, Peipei, et al.
Publicado: (2016)

Clinical impact of albumin in advanced head and neck cancer patients with free flap reconstruction—a retrospective study
por: Tsai, Ming-Hsien, et al.
Publicado: (2018)

Fundamentals of advanced mathematics 1: categories, algebraic structures, linear and homological algebra
por: Bourles, Henri
Publicado: (2017)

Radiomic Nomogram Improves Preoperative T Category Accuracy in Locally Advanced Laryngeal Carcinoma
por: Wang, Fei, et al.
Publicado: (2019)

Ten tips for advancing a culture of improvement in primary care
por: Kiran, Tara, et al.
Publicado: (2019)

COVID-19: categories of persons at high risk
por: Cook, Anna
Publicado: (2020)

The relationship between personality traits and BMI categories
por: Tekin, Emrah, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_jou99a4jlvq99p84am246ql3md